Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of Loperamide HCl 2 mg
and simethicone 125 mg tablets (Ranbaxy) with that of Imodium® Advanced caplets (McNeil) in
healthy subjects under fasting condition